Hans Olsson

3.7k total citations
61 papers, 1.9k citations indexed

About

Hans Olsson is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Hans Olsson has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 16 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Hans Olsson's work include Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (13 papers) and Breast Cancer Treatment Studies (7 papers). Hans Olsson is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (13 papers) and Breast Cancer Treatment Studies (7 papers). Hans Olsson collaborates with scholars based in Sweden, France and United States. Hans Olsson's co-authors include Ivan Shabo, Christer Halldin, Lars Farde, Joar Svanvik, Anna Nordström, Olle Stål, Staffan Jahnson, Sun Xiao, Svante Nyberg and Firas Aljabery and has published in prestigious journals such as PLoS ONE, NeuroImage and American Journal of Psychiatry.

In The Last Decade

Hans Olsson

59 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Olsson Sweden 26 552 448 402 322 280 61 1.9k
Gustavo Sevlever Argentina 28 505 0.9× 937 2.1× 309 0.8× 198 0.6× 209 0.7× 154 2.7k
Jennie Taylor United States 22 538 1.0× 1.2k 2.6× 172 0.4× 188 0.6× 323 1.2× 91 3.1k
Pierre A. Robe Netherlands 31 498 0.9× 1.4k 3.2× 278 0.7× 305 0.9× 246 0.9× 152 3.4k
Roberto Piñeiro Spain 20 508 0.9× 616 1.4× 184 0.5× 322 1.0× 100 0.4× 44 2.1k
Jiang Wu China 24 464 0.8× 405 0.9× 282 0.7× 177 0.5× 295 1.1× 101 1.9k
Andrew Morokoff Australia 28 217 0.4× 773 1.7× 240 0.6× 131 0.4× 405 1.4× 79 2.5k
Kinga Szigeti United States 24 333 0.6× 933 2.1× 188 0.5× 215 0.7× 812 2.9× 64 2.9k
Ilker Y. Eyüpoglu Germany 32 408 0.7× 1.4k 3.1× 271 0.7× 288 0.9× 399 1.4× 101 3.4k
Stéphan Saïkali France 23 303 0.5× 701 1.6× 181 0.5× 205 0.6× 135 0.5× 61 1.9k
Serguei Bannykh United States 26 236 0.4× 695 1.6× 343 0.9× 131 0.4× 207 0.7× 78 2.3k

Countries citing papers authored by Hans Olsson

Since Specialization
Citations

This map shows the geographic impact of Hans Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Olsson more than expected).

Fields of papers citing papers by Hans Olsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Olsson. The network helps show where Hans Olsson may publish in the future.

Co-authorship network of co-authors of Hans Olsson

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Olsson. A scholar is included among the top collaborators of Hans Olsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Olsson. Hans Olsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sjödahl, Gottfrid, Carina Bernardo, Gunilla Chebil, et al.. (2021). Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. European Urology. 81(5). 523–532. 89 indexed citations
2.
Aljabery, Firas, Ivan Shabo, Oliver Gimm, Staffan Jahnson, & Hans Olsson. (2018). The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 36(12). 530.e7–530.e18. 23 indexed citations
3.
Jönsson, Anna K., et al.. (2018). Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence. CNS Drugs. 32(1). 47–64. 43 indexed citations
4.
Shabo, Ivan, Henrik Andersson, Emma Åkerlund, et al.. (2015). Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction. BMC Cancer. 15(1). 922–922. 76 indexed citations
6.
Dreifaldt, Mats, John D. Mannion, Lennart Bodin, et al.. (2013). The No-Touch Saphenous Vein as the Preferred Second Conduit for Coronary Artery Bypass Grafting. The Annals of Thoracic Surgery. 96(1). 105–111. 49 indexed citations
7.
Olsson, Hans, Per Hultman, Johan Rosell, Peter Söderkvist, & Staffan Jahnson. (2013). MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1. BMC Urology. 13(1). 5–5. 17 indexed citations
8.
Björnsson, Bergþór, Anders Winbladh, Linda Bojmar, et al.. (2011). Remote or Conventional Ischemic Preconditioning –Local Liver Metabolism in Rats Studied with Microdialysis. Journal of Surgical Research. 176(1). 55–62. 8 indexed citations
9.
Guðjónsson, Sigurður, Gunilla Chebil, Staffan Jahnson, et al.. (2011). The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS). British Journal of Urology. 110(2b). E41–5. 7 indexed citations
10.
11.
Winbladh, Anders, Per Sandström, Hans Olsson, Joar Svanvik, & P. Gullstrand. (2009). Segmental Ischemia of the Liver – Microdialysis in a Novel Porcine Model. European Surgical Research. 43(3). 276–285. 8 indexed citations
12.
Nyberg, Svante, Maria Eriksdotter, Zsolt Cselényi, et al.. (2009). Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184. European Journal of Nuclear Medicine and Molecular Imaging. 36(11). 1859–1863. 70 indexed citations
13.
Shabo, Ivan, Hans Olsson, Sun Xiao, & Joar Svanvik. (2009). Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. International Journal of Cancer. 125(8). 1826–1831. 121 indexed citations
14.
Elander, Nils, Jonas Ungerbäck, Hans Olsson, et al.. (2008). Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APCMin/+ mice. Biochemical and Biophysical Research Communications. 372(1). 249–253. 36 indexed citations
15.
Olsson, Hans, et al.. (2003). Determination Of Transverse Dispersivities At Lab Scale: Conservative Transport And Steady State Reactive Plumes. AGUFM. 2003. 4 indexed citations
16.
Pike, Victor W., Christer Halldin, Kenji Nobuhara, et al.. (2003). Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT 4 receptors with SPET. European Journal of Nuclear Medicine and Molecular Imaging. 30(11). 1520–1528. 18 indexed citations
17.
Halldin, Christer, Stefan Pauli, Yuan-Hwa Chou, et al.. (2003). [ 11 C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. European Journal of Nuclear Medicine and Molecular Imaging. 30(9). 1220–1230. 86 indexed citations
18.
Nordström, Anna, et al.. (2003). Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457. The International Journal of Neuropsychopharmacology. 6(4). 361–370. 97 indexed citations
19.
Nordström, Anna, et al.. (2001). No Support for Regional Selectivity in Clozapine-Treated Patients: A PET Study With [11C]Raclopride and [11C]FLB 457. American Journal of Psychiatry. 158(6). 926–930. 66 indexed citations
20.
Nordström, Anna, Hans Olsson, & Christer Halldin. (1998). A PET study of D2 dopamine receptor density at different phases of the menstrual cycle. Psychiatry Research Neuroimaging. 83(1). 1–6. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026